Quantum量子訊息有限公司

Alopecia Market

完整報告名稱與涵蓋範圍
Alopecia Market Size, Share & Trends Analysis Report Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Androgenetic Alopecia, Alopecia Totalis, Alopecia Universalis), By Treatment (Pharmaceutical, Devices), By Gender (Male, Female), By Sales Channel (Prescriptions, OTC), By End-use, By Region, And By Segment Forecasts, 2024-2031

報告摘要

The worldwide Alopecia Market stood at USD 8.6 billion in 2023, and is anticipated to reach USD 17.8 billion by 2031, recording a CAGR of 9.8% from 2024 through 2031. Alopecia covers an autoimmune disease that damages hair follicles and causes hair loss. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. The market's upward path is underpinned by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in healthcare. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support. Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing. The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Alopecia Market Snapshot Chapter 4. Global Alopecia Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031 4.8. Global Alopecia Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031 4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023) 4.10. Use/impact of AI on Alopecia Industry Trends Chapter 5. Alopecia Market Segmentation 1: By Disease Type, Estimates & Trend Analysis 5.1. Market Share by Disease Type, 2023 & 2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Disease Type 5.2.1. Alopecia Areata 5.2.2. Cicatricial Alopecia 5.2.3. Traction Alopecia 5.2.4. Alopecia Totalis 5.2.5. Alopecia Universalis 5.2.6. Androgenetic Alopecia 5.2.7. Others Chapter 6. Alopecia Market Segmentation 2: By Treatment, Estimates & Trend Analysis 6.1. Market Share by Treatment, 2023 & 2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Treatments: 6.2.1. Pharmaceuticals 6.2.1.1. Topical 6.2.1.1.1. OTC 6.2.1.1.1.1. Minoxidil 6.2.1.1.1.2. Others 6.2.1.1.2. Prescription 6.2.1.1.2.1. Betamethasone Dipropionate 6.2.1.1.2.2. Fluocinolone Acetonide 6.2.1.1.2.3. Finasteride 6.2.1.1.2.4. Minoxidil 6.2.1.2. Oral 6.2.1.2.1. OTC 6.2.1.2.1.1 Prescription 6.2.1.2.1.1. Minoxidil 6.2.1.2.1.2. Finasteride 6.2.1.2.1.3. Corticosteroids 6.2.1.2.1.4. Others (JAK inhibitors and others) 6.2.1.2.2. PRP 6.2.2. Devices 6.2.2.1. Laser Cap 6.2.2.2. Laser Comb 6.2.2.3. Laser Helmet Chapter 7. Alopecia Market Segmentation 3: By Gender, Estimates & Trend Analysis 7.1. Market Share by Gender, 2023 & 2031 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Gender: 7.2.1. Male 7.2.2. Female Chapter 8. Alopecia Market Segmentation 4: By Sales Channel, Estimates & Trend Analysis 8.1. Market Share by Sales Channel, 2023 & 2031 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Sales Channel: 8.2.1. Prescriptions 8.2.2. OTC Chapter 9. Alopecia Market Segmentation 5: By End User, Estimates & Trend Analysis 9.1. Market Share by End User, 2023 & 2031 9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End User: 9.2.1. Homecare Settings 9.2.2. Dermatology Clinics Chapter 10. Alopecia Market Segmentation 6: Regional Estimates & Trend Analysis 10.1. Global Alopecia Market, Regional Snapshot 2023 & 2031 10.2. North America 10.2.1. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 10.2.1.1. US 10.2.1.2. Canada 10.2.2. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031 10.2.3. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031 10.2.4. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031 10.2.5. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031 10.2.6. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 10.3. Europe 10.3.1. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 10.3.1.1. Germany 10.3.1.2. U.K. 10.3.1.3. France 10.3.1.4. Italy 10.3.1.5. Spain 10.3.1.6. Rest of Europe 10.3.2. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031 10.3.3. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031 10.3.4. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031 10.3.5. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031 10.3.6. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 10.4. Asia Pacific 10.4.1. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 10.4.1.1. India 10.4.1.2. China 10.4.1.3. Japan 10.4.1.4. Australia 10.4.1.5. South Korea 10.4.1.6. Hong Kong 10.4.1.7. Southeast Asia 10.4.1.8. Rest of Asia Pacific 10.4.2. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031 10.4.3. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031 10.4.4. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031 10.4.5. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts By Sales Channel, 2024-2031 10.4.6. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 10.5. Latin America 10.5.1. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 10.5.1.1. Brazil 10.5.1.2. Mexico 10.5.1.3. Rest of Latin America 10.5.2. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031 10.5.3. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031 10.5.4. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031 10.5.5. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031 10.5.6. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 10.6. Middle East & Africa 10.6.1. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 10.6.1.1. GCC Countries 10.6.1.2. Israel 10.6.1.3. South Africa 10.6.1.4. Rest of Middle East and Africa 10.6.2. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031 10.6.3. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031 10.6.4. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031 10.6.5. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031 10.6.6. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 Chapter 11. Competitive Landscape 11.1. Major Mergers and Acquisitions/Strategic Alliances 11.2. Company Profiles 11.2.1. Janssen Global Services Inc. 11.2.1.1. Business Overview 11.2.1.2. Key Product/Service Offerings 11.2.1.3. Financial Performance 11.2.1.4. Geographical Presence 11.2.1.5. Recent Developments with Business Strategy 11.2.2. Cipla Limited 11.2.3. Merck & Co., Inc. 11.2.4. GlaxoSmithKline Plc 11.2.5. Sun Pharmaceuticals Industries Ltd 11.2.6. Dr Reddy's Laboratories Ltd 11.2.7. Aurobindo Pharma 11.2.8. Viatris Inc. 11.2.9. Pfizer, Inc. 11.2.10. Eli Lilly 11.2.11. Lexington Intl., LLC 11.2.12. Freedom Laser Therapy 11.2.13. Curallux, LLC 11.2.14. Apira Sciences Inc. 11.2.15. Revian Inc. 11.2.16. Theradome 11.2.17. Lutronic 11.2.18. iRestore Hair Growth System 11.2.19. iGrow Laser 11.2.20. Theradome 11.2.21. Other Prominent Players

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們